EQUITY METHOD INVESTMENTS (Tables)

12 Months Ended

Dec. 31, 2023

Equity Method Investments and Joint Ventures [Abstract]

Schedule of investments in an unconsolidated entity, AVLP

	Investment in			Investment in
	warrants and			promissory notes			Total
	common stock			and advances			investment
Balance at January 1, 2022	$	39,000		$	22,091,000		$	22,130,000
Investment in convertible promissory notes		-			2,200,000			2,200,000
Loss from equity investment		(39,000	)		(885,000	)		(924,000	)
Accrued interest		-			143,000			143,000
Loss on remeasurement upon conversion		-			(2,700,000	)		(2,700,000	)
Conversion of AVLP convertible promissory notes		-			(17,040,000	)		(17,040,000	)
Elimination of intercompany debt after conversion		-			(3,809,000	)		(3,809,000	)
Balance at December 31, 2022	$	-		$	-		$	-

Schedule of equity investments in unconsolidated entity – SMC

Rollforward investment in unconsolidated entity	Amount
Beginning balance - January 1, 2023	$	-
Equity method investment in SMC upon deconsolidation		2,259,000
Loss from investment in unconsolidated entity		(302,000	)
Ending balance - December 31, 2023	$	1,957,000

Schedule of summarized statements of operations

	For the Year Ended
	December 31,
	2023
Revenue	$	32,581,000
Gross profit	$	6,964,000
Loss from operations	$	(8,290,000	)
Net loss	$	(9,384,000	)

Schedule of summarized balance sheet information

	December 31,
	2023
Current assets	$	23,206,000
Non-current assets	$	4,509,000
Current liabilities	$	16,209,000
Non-current liabilities	$	3,928,000